Abstract
Objective: To provide a review of literature reporting empirically determined symptom clusters in lung cancer patients. Method: We conducted a literature search on symptom clusters in lung cancer patients using MEDLINE, EMBASE and CINAHL. Studies examining the presence of predetermined clusters were excluded. The five relevant studies identified were published between 1997 and 2009. Results: Overall, the five studies reported significantly diverse findings with regards to symptom cluster quantity and composition in lung cancer patients. The number of symptom clusters extracted varied from one to four per study. The number of symptoms in a cluster ranged from two to 11. The only cluster that was consistently identified in two studies was composed of nausea and vomiting symptoms. Respiratory clusters identified in two studies were also comparable, containing both dyspnea and cough, among other symptoms. Methodological disparities, including differences in sample population characteristics, assessment tools and analytical methods, were evident in the five studies reviewed. Conclusion: Symptom cluster exploration is a developing area of research in the oncology field and is promising in providing insights into diagnosis, prognostication and symptom management. Disparities in methodology are significant barriers to producing comparable results. These inconsistencies result in a lack of consensus in symptom clusters in lung cancer populations, thus impeding the determination of clinically relevant findings.
Acknowledgement
The authors are grateful for the support of the Michael and Karyn Goldstein Cancer Research Fund, Henry Lam from Sunnybrook library service and Stacy Yuen and Kristina Facchini for their assistance.
Financial & competing interests disclosure
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
No writing assistance was utilized in the production of this manuscript.